Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23712913.
- Also identified by DOI 10.1002/adma.201301046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The combination of chemo-thermal therapy is the best strategy to ablate tumors, but how to heat deep tumor tissues effectively without side-damage is a challenge. Here, a systemically delivered nanocarrier is designed with multiple advantages, including superior heat absorption, highly efficient hyperthermia, high drug capacity, specific targeting ability, and molecular imaging, to achieve both high antitumor efficacy and effective amplification of hyperthermia with minimal side effects.
Medical subject headings
- Antineoplastic Agents
- Brain Neoplasms
- Graphite
- High-Intensity Focused Ultrasound Ablation
- Magnets
- Nanostructures
- Oxides